Impact of the COVID-19 Pandemic on the Delivery of Dermatological Care

por Kimball, Alexa B., Porter, Martina L.
Publicado 2022

An Assessment of the Cost-Utility of Therapy for Psoriasis

por Weiss, Stefan C, Rehmus, Wingfield, Kimball, Alexa B
Publicado 2006

Response to Letter to the Editor entitled: Rethinking biologic and pregnancy research: The importance of assessing postpartum immunosuppression of the infant

por Gibson, Ruby S., Porter, Martina L., Kimball, Alexa B.
Publicado 2021

Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa

por Gibson, Ruby S., Porter, Martina L., Kimball, Alexa B.
Publicado 2022

33892 Telehealth use at a specialty hidradenitis suppurativa clinic during the COVID-19 pandemic

por Kim, Diana S., Kimball, Alexa B., Porter, Martina L.
Publicado 2022

Update on biologic safety for patients with psoriasis during pregnancy

por Porter, Martina L., Lockwood, Stephen J., Kimball, Alexa B.
Publicado 2017

TNF-α inhibitors in the treatment of hidradenitis suppurativa

por Savage, Kevin T., Flood, Kelsey S., Porter, Martina L., Kimball, Alexa B.
Publicado 2019

Career satisfaction of leaders in academic dermatology: Results from a national survey,()

por Sadeghpour, Mona, Sung, Sarah M., Jacobe, Heidi, Kimball, Alexa B.
Publicado 2019

Travel burden on patients at a subspecialty hidradenitis suppurativa clinic: a single-center retrospective study

por Kim, Diana S., Giannotti, Nicole, Salian, Prerna, Kimball, Alexa B., Porter, Martina L.
Publicado 2022

Telehealth Use by Age and Race at a Single Academic Medical Center During the COVID-19 Pandemic: Retrospective Cohort Study

por Stevens, Jennifer P, Mechanic, Oren, Markson, Lawrence, O'Donoghue, Ashley, Kimball, Alexa B
Publicado 2021

Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients

por Savage, Kevin T., Santillan, Monica Rosales, Flood, Kelsey S., Charrow, Alexandra, Porter, Martina L., Kimball, Alexa B.
Publicado 2020

Challenges for dermatologists during the COVID-19 pandemic: A qualitative study

por Helm, Matthew F., Kimball, Alexa B., Butt, Melissa, Stuckey, Heather, Costigan, Heather, Shinkai, Kanade, Nagler, Arielle R.
Publicado 2022

Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa

por Savage, Kevin T., Brant, Elena Gonzalez, Rosales Santillan, Monica, Morss, Peyton C., Salian, Prerna, Flood, Kelsey S., Porter, Martina L., Kimball, Alexa B.
Publicado 2020

Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice

por Prens, Errol P., Lugo-Somolinos, Aida M., Paller, Amy S., Kerdel, Francisco, Duan, Yinghui, Teixeira, Henrique D., Longcore, Michelle, Kimball, Alexa B.
Publicado 2020

Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities

por Morss-Walton, Peyton C., Greif, Charlotte, Holcomb, Zachary E., Salian, Prerna, Yankama, Tuyen, Kim, Diana, Porter, Martina L., Kimball, Alexa B.
Publicado 2022

Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study

por Garg, Amit, Geissbühler, Yvonne, Houchen, Emma, Choudhary, Nilesh, Arora, Disha, Vellanki, Varun, Srivastava, Abhishek, Priyanka, Darcy, John, Richardson, Craig, Kimball, Alexa B.
Publicado 2023

Efficacy and safety of mirikizumab in psoriasis: results from a 52‐week, double‐blind, placebo‐controlled, randomized withdrawal, phase III trial (OASIS‐1)

por Blauvelt, Andrew, Kimball, Alexa B., Augustin, Matthias, Okubo, Yukari, Witte, Michael M., Capriles, Claudia Rodriguez, Sontag, Angelina, Arora, Vipin, Osuntokun, Olawale, Strober, Bruce
Publicado 2022

Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy

por Holcomb, Zachary E., Santillan, Monica Rosales, Morss-Walton, Peyton C., Salian, Prerna, Her, Min Ji, Giannotti, Nicole M., Kimball, Alexa B., Porter, Martina L.
Publicado 2020

Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

por Kimball, Alexa B., Guenther, Lyn, Kalia, Sunil, de Jong, Elke M. G. J., Lafferty, Kimberly Parnell, Chen, Dan Y., Langholff, Wayne, Shear, Neil H.
Publicado 2021

Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database

por Clowse, Megan E. B., Scheuerle, Angela E., Chambers, Christina, Afzali, Anita, Kimball, Alexa B., Cush, John J., Cooney, Maureen, Shaughnessy, Laura, Vanderkelen, Mark, Förger, Frauke
Publicado 2018